Davies's research group has an international reputation for work on Duchenne muscular dystrophy (DMD). In the 1980s, she developed a test which allowed for the screening of foetuses whose mothers have a high risk of carrying DMD. DMD occurs when the dystrophinprotein fails to express in muscle cells due to a mutation in the gene which codes for the protein. In 1989 Davies discovered that the utrophin protein has similar properties to dystrophin and has since shown in mouse models that up regulation of the former protein in muscle cells can compensate for the absence of latter.[10]
Davies is currently[when?] collaborating with European Research Council fellow Dr Peter Oliver investigating neurodegenerative and movement disorders.[11]
She has published more than 400 papers and won numerous awards for her work. She has been a Governor of the Wellcome Trust since 2008 and became Deputy chairman in 2013-18. She was the recipient of the Women in to Science and Engineering (WISE) Lifetime Achievement Award in 2014.[15]
Davies was awarded the Croonian Lecture by the Royal Society in 2018 for "her achievements in developing a prenatal test for Duchenne muscular dystrophy and for her work characterising the binding partners of the protein dystrophin".[21]
Personal life
Davies continued to work with her former husband, Stephen G. Davies, on scientific projects, even after their separation in 2000.[5] Their son {2006-2015} studied Biology and gained a doctorate at the University of Edinburgh. She married Christopher Williams in 2019.[22]
^National Academy of Medicine, National Academy of Sciences, and the Royal Society. 2020. Heritable Human Genome Editing. Washington, DC: The National Academies Press. https://doi.org/10.17226/25665.
^Anon (2003). "Dame Kay Davies DBE FMedSci FRS". London: royalsociety.org. Archived from the original on 17 November 2015. One or more of the preceding sentences incorporates text from the royalsociety.org website where: